Conducted entirely in Europe across forty sites in five countries, this rigorous study met all clinical endpoints
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
Raludotatug deruxtecan is a specifically engineered, potential first-in-class CDH6-directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo
The survey revealed that the proportion of individuals experiencing constant thoughts about food throughout the day declined by 46 percent after starting Wegovy
Advent acquired Zentiva from Sanofi in 2018 and transformed the company into a highly successful standalone business
Cagrilintide represents a novel approach to obesity management
The cGMP-4 facility will further strengthen the company's ability to serve global partners
Vonvendi is the only recombinant Von Willebrand factor replacement therapy with approved indications in adults and children with VWD
PendraCare Group develops, manufactures and sells innovative cardiology catheter solutions and provides design, development and manufacturing services to other global OEM’s
Subscribe To Our Newsletter & Stay Updated
